Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
190 hedge funds and large institutions have $2.8B invested in Medicines Co in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 76 increasing their positions, 60 reducing their positions, and 18 closing their positions.
90% more call options, than puts
Call options by funds: $62.4M | Put options by funds: $32.8M
56% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 18
43% more funds holding in top 10
Funds holding in top 10: 7 → 10 (+3)
27% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 60
7% more capital invested
Capital invested by funds: $2.62B → $2.8B (+$186M)
5% more funds holding
Funds holding: 181 → 190 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$22.8M |
| 2 |
First Eagle Investment Management
New York
|
+$19.6M |
| 3 |
Millennium Management
New York
|
+$19.2M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$13.8M |
| 5 |
BC
Broadfin Capital
New York
|
+$9.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$24.3M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$17.6M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.62M |
| 5 |
Renaissance Technologies
New York
|
-$9.13M |
MDCO Hedge Fund Activity: Q2 2016 in Review
190 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q2 2016, worth a combined $2.8B — up 7.1% from $2.62B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new MDCO positions and 18 closed out — a net gain of 10 holders — while 76 added to existing stakes and 60 trimmed.
The largest buyer was Macquarie Group, adding an estimated $22.8M. The largest seller was Bridger Management, cutting an estimated $24.3M.
- 190 institutional investors held Medicines Co (MDCO) as of Q2 2016, up from 181 in Q1 2016.
- Funds reported $2.8B of Medicines Co stock for Q2 2016, up 7.1% quarter-over-quarter.
- 28 funds opened new Medicines Co positions in Q2 2016 and 18 closed out, a net change of +10 holders.
- The largest Medicines Co buyer in Q2 2016 was Macquarie Group, an estimated $22.8M added.
- The largest Medicines Co seller in Q2 2016 was Bridger Management, an estimated $24.3M sold.
Based on aggregated 13F filings for Q2 2016.